- Report
- May 2025
- 194 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 198 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 190 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 180 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 181 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 194 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 190 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 138 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- November 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- January 2025
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- April 2025
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- February 2025
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 278 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP

Biomarker assays are laboratory tests used to measure the presence and/or concentration of biomarkers in biological samples. Biomarkers are molecules, genes, or other characteristics that can be used to measure the presence or progression of a disease, or to measure the effectiveness of a treatment. Biomarker assays are used in a variety of medical and research applications, including diagnostics, drug development, and personalized medicine.
The biomarker assay market is a rapidly growing segment of the healthcare industry, driven by advances in technology and the increasing demand for personalized medicine. The market is expected to grow due to the increasing prevalence of chronic diseases, the growing demand for early diagnosis, and the increasing use of biomarkers in drug development.
Some of the major companies in the biomarker assay market include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Becton Dickinson, and Roche Diagnostics. Show Less Read more